re-exposure to proliferation medium led to a very similar proliferation profile as seen in NSPCs not exposed to quiescence, there were still significant differences, which were gone after 6 days of re-exposure to proliferation medium. Bars represent mean ± SEM. C) The neurogenic potential upon differentiation was not altered upon previous quiescence exposure, further demonstrating the reversibility of the system. Shown are representative images of NSPCs that were allowed to spontaneously differentiate for 9 days upon growth factor removal.
Prior to differentiation, NSPCs were either exposed 3 days to quiescence cues followed by 3 days proliferation medium (ex quie-diff) or kept all the time under proliferation conditions (prol-diff). Map2ab marks neurons. Quantification represents mean ± SEM. D) Comparative analysis of the proteome of proliferating and quiescent NSPCs reveals proteins involved in FAO to be enriched in quiescent NSPCs. The dot plot shows proteins changed significantly at least two fold (log 2 ≥ |1|) in quiescent (red) and proliferating (green) NSPCs. E) Shown is the median abundance of proteins belonging to the represented GO terms. Only the GO term "Fatty acid oxidation" was changed more than 2 fold (median higher than log 2 ≥ |1|). F) Histograms show the normalized abundance of proteins belonging to the indicated GO terms, detected in the mass spectrometric comparison of proliferating and quiescent NSPCs. (Gray = expression change of log 2 < |1|, red = expression change of log 2 ≤ -1, enriched in quiescent NSPCs, green = expression change of log 2 ≥ 1, enriched in proliferating NSPCs). G) Acetyl-CoA does not differ significantly between quiescent and proliferating NSPCs, as measured by mass spectrometry (mean + SEM). H) Cpt1a in proliferating NSPCs co-localizes with the mitochondrial marker Mitotracker.
Shown are representative confocal images of maximum projections of individual channels and a 3D-reconstruction. Right bars show the percentage of cells in Sub-G1 as a readout for cell death.
100µM Etomoxir lead to a mild but significant increase in cell death. C) The decrease in proliferation upon Etomoxir treatment is also apparent using an EdUpulse to label cells in S-phase. With 50µM or 100µM Etomoxir for 24h, the amount of proliferating NSPCs decreased significantly, whereas the increase in cell death (cleaved caspase-3) was mild and non-significant. Shown are representative images of the different conditions and quantification of proliferation and cell death. D) Treatment with the PPARα agonist WY14643 led to an upregulation of PPARα target FAO genes in proliferating NSPCs compared to control NSPCs, however, to a far lesser extent than in quiescent NSPCs.
Shown are the mRNA expression levels (mean fold change ± range) of multifunctional protein 1 (Mfp1), Acyl-CoA oxidase 1 (Acox1), peroxisomal 3-ketoacyl-CoA thiolase A (Acaa1a) and peroxisomal biogenesis factor 11 alpha (Pex11a).
Scale bars: 50µm; ***p < 0.001, **p < 0.01. Shown is a representative confocal image (maximum projection) from a 2-monthold Cpt1a-GFP reporter mouse. Dotted lines show the outline of the granular zone of the DG. C) Co-staining for Cpt1a-GFP and endogenous Cpt1a protein shows that the Cpt1a-GFP reporter mouse faithfully reports Cpt1a expression.
Shown is a representative confocal image (maximum projection) from a 2-month- Scale bar represents 50µm. ***p < 0.001, **p < 0.01, * p < 0.05. (Schoors et al., 2015) N/A Mouse: Spot14CreERT2 mice (S14iCre) (Knobloch et al., 2013) LentiLox3.7 U6 shRNA (pLL3.7) Addgene #11795 LentiLox3.7 mcherry U6 shRNA (Knobloch et al., 2013 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Mice were kept in a specific pathogen free ( Genotyping was performed using 5'-CTGGTGCCAGGCTTCTAA-3' forward and 5'-TAGCGGCTGAAGCACTGCA -3' reverse primers. Six females were used for histological analyses at the age of two months. For in utero electroporation experiments, time-mated C57BL/6JRj female mice were obtained from Janvier Labs (France). Cpt1a cKO mice (Schoors et al., 2015) were embryo-transferred through C57BL6/J (Jackson laboratory) and kept thereafter on a heterozygous level by crossing them with C57BL/6JRj (Janvier Labs, France). They were crossed with Spot14CreERT2 mice (S14iCre (Knobloch et al., 2013) ) and ROSA26 YFP reporter mice (R26YFP, B6.129X1-Gt(ROSA)26Sor tm1(EYFP)Cos /J, kept for more than 10 generations on a C57BL/6J background) to obtain S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt and S14iCre +/-; Cpt1a cKO fl/fl; R26YFP fl/wt littermates. Breedings were set up in a way that all the genotypes were generated within one litter and that several litters were born within one week.
Littermates were assigned to the different groups based on genotype. Due to low recombination efficiency, Cre-mediated recombination was induced by five intraperitoneal injections of tamoxifen on five consecutive day (Sigma, 180mg/kg, dissolved in cornoil) at the age of six to seven weeks. All animals received tamoxifen. Animals were perfused either eight days or twenty-five days after first tamoxifen injections. For the eight day timepoint, one male and three females of S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt and one male and five females of S14iCre +/-; Cpt1a cKO fl/fl; R26YFP fl/wt were induced. One S14iCre +/-; Cpt1a cKO fl/fl female had to be excluded from the analysis, as no YFP positive cells were detected in the DG. For the twenty five day timepoint, two males and three females of S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt and one male and six females of S14iCre +/-; Cpt1a cKO fl/fl; R26YFP fl/wt were induced. Two S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt (one male, one female) had to be excluded from the analysis, as no YFP positive cells were detected in the DG.
All animal experiments were performed according to Swiss regulatory standards and approved by the Veterinary office of the Canton of Zurich.
Cells
Primary adult mouse DG (mDG) NSPCs were obtained and cultured as previously described (Knobloch et al., 2013; Ray and Gage, 2006) . In brief, DGs from eight female C57BL6/J (Jackson laboratory) were subdissected and processed as described (Ray and Gage, 2006) . Early passages were frozen and kept in liquid nitrogen. Experiments were performed with cells up to passage 20.
Mycoplasma tests were performed on a regular base to verify that cells were mycoplasma free. Mouse liver hepatome cells (Hepa1-6 cells) were grown as suggested by the provider, Leibnitz Institute DSMZ (Catalogue code: ACC 175).
Plasmids
Cpt1a shRNA sequence was designed using the RNAi Consortium hairpin candidate sequences selection (www.broadinstitute.org/rnai/trc) against mouse Cpt1a (NM_013495). The sequences of the oligonucleotides used are as follows: TCCTAAGGTTAAGTCGCCCTTTCAAGAGAAGGGCGACTTAACCTTAGGTTTT TTC The shRNA knockdown constructs (derived from LentiLox3.7) were cloned to express mCherry under the CMV promoter and shRNAs under the U6 promoter.
METHOD DETAILS
Cell culture
Primary mDG NSPCs were kept as monolayer cultures in DMEM/F12 Glutamax medium supplemented with N2 (Invitrogen), human EGF (20 ng/ml), human basic FGF-2 (20 ng/ml, Peprotech) and Heparin (5mg/ml, Sigma). Medium contained an antibiotic/antimycotic (Anti-Anti, Thermo Fisher Scientific). This proliferation medium was changed every 2-3 days.
For all experiments involving quiescence induction and/or immunocytochemistry, cells were plated on glass coverslips or multi-well cell culture dishes coated with Poly-L-ornithine (Sigma, 10µg/ml for plastic, 50µg/ml for glass) and Laminin (Invitrogen, 5µg/ml). All experiments were done with a minimum of 3 coverslips per condition.
Quiescence was induced as previously described (Martynoga et al., 2013; Mira et al., 2010) . In brief, exchanging EGF with recombinant mouse BMP4 (RnD Systems) results in a significant drop in proliferation over the course of 3 days with almost no more proliferation detectable after 3 days. This artificial quiescence is fully reversible after replating NSPCs in proliferation medium. For all quiescence experiments, cells were plated in proliferation medium (~40'000 cells/cm 2 ) and switched the next day to quiescence medium, which was composed of DMEM/F12 Glutamax supplemented with N2, human basic FGF-2 (20 ng/ml), Heparin (5mg/ml) and BMP4 (50ng/ml, BMP4 stock dissolved in 4mM HCL/PBS/0.5%BSA). Cells were kept for a minimum of 3 days in quiescence medium before fixation or harvest. For comparisons with proliferating NSPCs, cells were plated in parallel at a lower density (~14'000 cells/cm 2 ) and kept in proliferation medium over the same time period as the quiescent NSPCs, with medium change every 2 days. To reverse quiescence, NSPCs were collected after 3 days of quiescence and replated in fresh proliferation medium (~50'000 cells/cm 2 ). To compare the proliferation rate of formerly quiescent NSPCs to cells that had not entered quiescence, proliferating NSPCs that were grown in parallel were also replated in fresh proliferation medium at slightly lower density (~30'000 cells/cm 2 ). For extended reversal of quiescence (6 days proliferation medium after quiescence), cells were replated as described above and split again 3 days later. For the experiments were effects of compounds on quiescence were tested cells were treated as followed: full quiescence was established as described above for 3 days, cells were washed off the plate with old medium, trypsinized with 2.5% Trypsin diluted to .05% in Versene (Invitrogen) and blocked with a trypsin Inhibitor Mix (L-15 medium, 0.1% ovomucoid trypsin inhibitor (Sigma), 0.05% BSA and 0.01% DNAse I type IV). Cells were spun down in PBS, counted and plated onto freshly coated plates in fresh quiescence medium (~220'000 cells/cm 2 ). 100 µM or 200 µM Malonyl-CoA (Sigma) was added as outlined in the corresponding figures. 20 µM Orlistat (Xenical, Roche) was used as previously described (Knobloch et al. 2013) . The PPARα agonist Wy14643 (Enzo Life Science) was dissolved in 100%
EtOH and 100µM was added to proliferating NSPCs for 48h. The same amount of 100% EtOH was added to proliferating NSPCs as a control. After 48h, cells were either collected for RNA isolation (see below) or incubated with EdU (5-ethynyl-2'-deoxyuridine, Invitrogen, 10µM, 1h pulse at 37°C in cell culture incubator), fixed and processed for immunocytometry as described below.
To assess the knockdown efficiency of the Cpt1a-shRNA construct, mouse liver hepatoma cells (Hepa 1-6 cells) that naturally express high Cpt1a levels were transfected with the 2 different constructs, using lipofectamine-2000 (Thermo Fisher). 48h later, cells were lysed and analyzed by Western blot as described below.
Time-lapse imaging and analysis
For time-lapse imaging, NSPCs were plated as described above in coated plastic cell culture plates in triplicates for each condition. Cells were placed in a heated and CO 2 -controlled chamber of an inverted microscope (Zeiss, Axio Observer) and 4-6 adjacent areas were imaged every 4h. Stitched phase contrast images were analysed using ImageJ. Several processing steps (bandpass filtering, Gaussian blurs, thresholding) were used to automatically analyze the area covered by cells.
Proteomics analysis
Sample preparation
Proliferating and quiescent NSPCs were cultured as described above on coated 10cm plates. Prior to protein extraction cells were washed twice using 4°C cold PBS (Life Technology). Cells were lysed using 300µl lysis buffer (150mM NaCL, 50mM Tris, 5mM EDTA, 20mM N-Ethylmaleimide, 2mM PMSF, 1x Complete EDTA-free proteinase Inhibitor tablets, ROCHE). Lysates were collected in precooled screw cap tubes (Sarstedt). Lysates were supplemented with 1.7%
Triton (Sigma) and 1% Chaps (Sigma) and incubated for 1h with end over end rotation at 4°C. Lysates were cleared by centrifugation at 17000g for 10min and protein concentration was determined using Protein DC assay (Biorad) following the Manufacturer's instructions. 100µg protein was precipitated twice by methanol/chloroform precipitation and protein pellets were resuspended in SDS lysis buffer (4% (w/v) SDS, 100mM Tris/HCL pH 8.2, 0.1M DTT) and stored at -80°C. Protein samples were processed using a modified protocol by filter aided sample preparation (FASP) (Wisniewski et al., 2009 ). In brief, samples were incubated for 5 min at 95°C with 700 rpm shaking on a head block (Eppendorf), followed by 10min sonication. Protein concentration was measured using a Qubit Mascot dat-files were imported into Scaffold 4 (Proteome Software) and the false discovery rate (FDR) for peptides was set to 0.01, for proteins to 0.05 respectively. The Scaffold Spectrum Report was re-imported into Progenesis and relative quantitation using non-conflicting peptides was performed. Decoy hits were excluded and protein quantitation and statistics were exported as .csv files.
Gene Ontology analysis
Gene names, p-values and normalized protein abundance were exported to Metacore 6.24 build 67895 (Thomson Reuters). Members corresponding to the GO terms: GO:0019395, GO:0006633, GO0006096, GO:0006098, GO:0008652, GO:0006099, GO: 0022904, GO:0006754 were exported. Changes in protein abundances were represented as histograms using Prism 6 (Graphpad).
Radioactive FAO measurements
Radioactively labeled palmitic acid ([9,10-3 were purchased from Perkin Elmer.
FAO of [9,10-3 H(N)]palmitic acid was assessed by the production and release of tritiated water according to a modified procedure (Djouadi et al., 2003) .
Proliferating and quiescent NSPCs were grown in 24-well plates as described above and the tritiated water release experiments were performed in triplicate (3 wells per sample/condition). A 500µM stock solution of [9, was sealed with parafilm to avoid evaporation and incubated for 2.5h at 37 °C. In some experiments, 100µM Etomoxir was added to wells as a negative control.
During the incubation, acidification vials with a 14 CO 2 trap were prepared by adding 200µl of 1M perchloric acid (Sigma) to tubes that contained a Whatman filter paper disc inside the cap that had been wetted with 20µl of 1M NaOH. At the end of the incubation, 400µl of the reaction mixture was added into an acidification vial to stop the reaction and incubated for 1h at room temperature.
The paper disc was transferred to a scintillation vial, mixed with 5ml of scintillation liquid and quantified by scintillation counting. After removal of the reaction mixture cells were washed with PBS and lysed in 0.1M NaOH for protein determination using the BCA procedure (Pierce).
Radioactive malonyl-CoA incorporation measurements
Cells were incubated with 0.5 µCi [2-14 C]malonyl-CoA (55 mCi/mmol; Cat. No.
ARC 0528, American Radiolabeled Chemicals, USA) and 100 µM malonyl-CoA.
After incubation, the cells were rinsed three times with PBS, and lipids were extracted with hexane:isopropanol ( 
In utero electroporation and tissue preparation
In-utero electroporation of mouse embryos (embryonic day 13, E13) from timemated C57BL/6JRj female mice was carried out as described previously (Asami et al., 2011) . In brief the shRNA plasmid DNA (Cpt1a-shRNA1 or non-targeting shRNA; final concentration 0.5-0.7µg/µl) was targeted into the ventricular wall by repeated electrical pulses (ElectroSquireporator T830, Harvard Apparatus). After 24h (corresponding to developmental stage E14), electroporated brains were dissected in ice cold PBS and fixed in phosphate buffered 4% paraformaldehyde (PFA; Sigma) on 4°C for 2 hrs. After rinse in PBS, embryonic brains were dehydrated in 30% sucrose (in PBS), embedded and frozen in OCT compound (Tissue-Tek; Sakura), and cut in slices of 30µm thickness using a Cryostat (Microm).
Tissue preparation, Immunohistology and Immunocytochemistry
Mice were transcardially perfused with 0.9% saline solution followed by 4% PFA solution. Brains were taken out and post-fixed overnight at 4°C in 4% PFA. After dehydration in 30% sucrose, 40µm thick free-floating sections were cut on a microtome (Leica). Sections were blocked for 1h with blocking buffer (0.25%
Triton-x, 3% donkey serum in PBS) and subsequently incubated with primary antibodies in blocking buffer at 4°C overnight. Sections were washed 3x with PBS and incubated for several hours at room temperature with secondary antibodies in blocking buffer. Nuclei were stained with DAPI. After another 3
washes with PBS sections were mounted (Shandon Immu-mount, Thermo Scientific). For Spot14 stainings, section were pretreated for 5h at RT with a buffer containing 1%Triton-x and 3% donkey serum, followed by 3 days primary antibody incubation in blocking buffer. An additional enhancement step with a biotinylated secondary antibody followed by a streptavidin-coupled fluorophore was used. Cells were fixed with 4%PFA (37°C, fixed at RT for 20min), washed 3x
with PBS and incubated in blocking buffer for 1h. Antibody stainings were done overnight at 4°C, secondary antibodies were incubated 2-4h at RT.
The following primary antibodies and dilutions were used: mouse anti-pH3
(1:1000, Abcam), mouse anti-Cpt1a (1:500, Abcam), rabbit anti-Ki67 (1:500m, Novocastra), chick-anti-GFP (1:500, Aves), goat anti-Sox2 (1:500, Santa Cruz), 
Image acquisition and analysis
Images of cell stainings were acquired using an Epifluorescent microscope (Zeiss Axiovert Observer). Images were analysed using ImageJ with customized macros for automated detection in a blinded manner. For differentiated cells, confocal microscopy (LSM-700, Zeiss) was perfomed and z-projections were generated for analysis in ImageJ. Images were thresholded, a watershed filter was applied and DAPI positive nuclei were counted with the analyze particle function. To quantify MAP2ab positive cells masks of the MAP2ab channel were generated and DAPI positive nuclei inside the MAP2ab mask were counted using the particle analyzer. Image acquisition and analysis were performed in a blinded manner. For co-localization experiments, confocal microscopy (LSM-700, Zeiss, FV1000; Olympus) was performed. Images of brain tissue were acquired using a Zeiss AxioImager microscope (for DAB stainings) or by confocal microscopy (LSM-700, Zeiss). One-to-two series of sagittal sections (corresponding to a 6th-3rd of the entire brain) were used from 2 months old Cpt1a-EGFP reporter mice (n=3-6) for quantification. To determine the percentage of Sox2 and DCX cells that were Cpt1a-eGFP+, analyses were carried out using both softwares Imaris (Bitplane) and ImageJ software. In Imaris, a surface was first created using either the Sox2 or DCX channel. Subsequently, this surface was used to mask the GFP signal. A snapshot of the maximum projection of each raw channel as well as each masked channel was saved for further import into ImageJ. To demarcate the SGZ, DAPI and DCX images were merged to outline the specified region. Bright Sox2 or DCX positive cells within the SGZ were circled to create region of interests (ROIs). These ROIs were then overlaid onto the masked GFP channel to determine if the Sox2+ or DCX+ cells were Cpt1a-eGFP+. At least 3
sections from 3 different animals were used to count >50 cells for each condition.
The same procedure was used to determine the number of Nestin-positive processes that also were Cpt1a-eGFP+.
For the in utero electroporation experiments, images were analyzed in a blinded manner with ImageJ. A region of interest was drawn over the mCherry positive area (stained as described above) from the ventricular zone to the pial surface. This region of interest was then applied to the adjacent sections stained against cleaved Caspase 3. A threshold was set and the %area covered by
Caspase-3 positive cells was measured. 4-5 sections per embryo were analyzed (non-targeting n=4 embryos, Cpt1a shRNA1 n=5 embryos). For pH3 quantification, regions with mCherry signal were selected and signal intensity of corresponding adjacent sections stained for pH3 were analyzed with ImageJ.
Mean gray values 40µm from the apical surface into the ventricular zone were measured along the electroporated area and plotted in relation to distance. 3-4 sections per embryo were analyzed (non-targeting n=3 embryos, Cpt1a shRNA1 n=4 embryos).
Clonal analysis
Serial 40µm sections of an entire hemisphere per mouse were stained with antibodies against GFP, Sox2 and doublecortin (DCX). All sections containing GFP positive cells were imaged with a 20x confocal microscope (for cellular identification) as well as with a 5x Epifluorescent microscope (for reconstruction).
Cell identity was determined in a blinded manner based on the following criteria, similar to what has been previously described (Bonaguidi et al., 2011) .
RT-PCRs
RNA of proliferating, quiescent, re-plated proliferating and formerly quiescent NSPCs ( and approximately 10 ng of cDNA template. Thermal cycling was carried out with a 5 min denaturation step at 95 °C, followed by 45 three-step cycles: 10 sec at 95 °C, 10 sec at 60 °C, and 10 sec at 72 °C. Finally, melt curve analysis was carried out to confirm the specific amplification of a target gene and absence of primer dimers. All reactions were run in duplicate. Relative mRNA amount was calculated using the deltadelta Ct methods. Cyclophilin was used as the invariant control. Results were confirmed with 18S rRNA as the invariant control (data not shown). Primers used are listed in Table S3 .
Western Blot
Proliferating and quiescent NSPCs were lysed in RIPA buffer containing protease inhibitors (Complete, Roche). Protein amount was determined with a BC assay (Uptima) and equal amounts of proteins were separated by SDS-PAGE electrophoresis followed by transfer to PVDF membrane (BioRad). Membranes were incubated with mouse anti-Cpta1 (1:2000, Abcam) and mouse anti-betaactin (1:10'000, Sigma). HRP-conjugated secondary antibodies (Jackson immunoResearch) were used and signal was revealed by enhanced chemiluminescence substrate (ThermoScientific).
Malonyl-CoA and acetyl-CoA measurements
Proliferating and quiescent NSPCs were washed with 75mM ammonium carbonate pH 7.4 and plates were snap frozen with liquid nitrogen. Metabolites were extracted with cold acetonitrile:methanol:water solvent (40:40:20) at -20°C for 10 minutes and an extraction step was repeated once. Samples were centrifuged at 13000rpm for 3 minutes and kept at -80°C. Extracts were dried by vacuum-centrifugation, re-suspended in 50µl water and analyzed by LC-MS/MS on a Thermo Quantum Ultra instrument equipped with a Waters Acquity UPLC (Buescher et al., 2010) . Data analysis was performed using our own software written in Matlab (The Mathworks). Cell numbers of proliferating and quiescent NSPCs were assessed in separate plates grown in parallel using live Hoechst (5µg/ml, Invitrogen). 12 low magnification images from each triplicate were taken and the number of nuclei counted using ImageJ. Measured malonyl-and acetylCoA values were normalized to the average cell number.
C13-incorporation and energy charge measurements
Proliferating and quiescent NSPCs were incubated for 24h with the corresponding medium containing 100µM C13-labelled palmitate (Cambridge Isotope Laboratories Inc.). Palmitate was coupled to BSA to achieve better cellular uptake. Metabolites were extracted with 800µL 80% methanol (at -80 °C), cells were scraped and the extracts were transferred to a 1.5ml tube. Next the extracts were centrifuged at 4°C for 15min at 20,000xg. The supernatant was dried using a vacuum centrifuge. To the dried fractions 25µL of a 2% methoxyamine hydrochloride solution (20mg dissolved in 1mL pyridine) was added and placed at 37°C for 90min. Then 75µl of N-tert-Butyldimethylsilyl-Nmethyltrifluoro-acetamide with 1% N-tert-Butyldimethyl-chlorosilane (SigmaAldrich, Belgium) was added and the reaction was carried out for 30min at 60°C.
Reaction mixtures were centrifuged for 15min at 20,000xg at 4°C in order to remove insolubilities, and the supernatant was transferred to a glass vial with conical insert (Agilent). GC-MS analyses were performed using an Agilent 7890A Temperature of the quadrupoles was maintained at 150°C. The injection volume was 1µl, and samples were injected at 1:10 split ratio. Helium flow was kept constant at 1 ml/min. The temperature of the column started at 100 °C for 5 min and increased to 260 °C at 2°C/min. Next, a 40°C/min gradient was carried out until temp reached 300°C. After the gradient, the column was heated for another 3 min at 325°C. The GC-MS analyses were performed in Single Ion Monitoring (SIM) scanning for the isotopic pattern of metabolites.
For energy charge measurements (which is defined as following:
(ATP+0.5*ADP)/(ATP+ADP+AMP)), metabolites of proliferating and quiescent
NSPCs were extracted using 250 uL of an 80% methanol solution. Measurement of ATP, ADP and AMP levels was performed using a Dionex UltiMate 3000 LC System (Thermo Scientific) coupled to a Q Exactive Orbitrap mass spectrometer (Thermo Scientific) operated in negative mode. Practically, 30 µl of sample was injected on a SeQuant ZIC/ pHILIC Polymeric column (Merck Millipore). The gradient started with 20% of solvent B (2 mM Na-acetate in mqH 2 O, pH 9.3) and 80% solvent A (95:5, acetonitrile:mqH 2 O, containing 2 mM Na-acetate at pH 9.3) and remained at 20% B until 2 min post injection. Next, a linear gradient to 80% B was carried out until 29 min. At 38 min the gradient returned to 40% B followed by a decrease to 20% B at 42 min. The chromatography was stopped at 58 min.
The flow was kept constant at 100 uL/min at the column was placed at 25°C throughout the analysis.
The MS operated both in full scan mode using a spray voltage of 3.2 kV, capillary temperature of 320°C, sheath gas at 10.0, auxiliary gas at 5.0. AGC target was set at 1e6 using a resolution of 70.000, with a maximum IT of 100 ms. Data collection was performed using Xcalibur software (Thermo Scientific).
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantifications were done as described in the METHOD DETAIL section.
Statistical analyses were performed with the software Prism 6 (GraphPad).
Significance levels were set at *p < 0.05, **p < 0.01 and ***p < 0.001.
The following tests were used: clones for S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt, n=17 clones for S14iCre +/-; Cpt1a cKO fl/fl; R26YFP fl/wt. D: grouped analysis, multiple t-tests, two tailed, n= 4 mice for S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt, n=5 mice for
